BD Ships Smallpox Vaccine Needles Globally
FRANKLIN LAKES, NJ - Syringe and Needle manufacturing giant Becton, Dickinson has begun shipping a specialized needle necessary for administering the smallpox vaccine worldwide.
The FDA-cleared, European CE marked bifurcated needle has two tiny prongs that hold the vaccine. The design was also used by the World Health Organization (WHO) during the smallpox eradication campaign of the 1970s. The BD device, however, is individually sterilized and hard-packaged for safety and biodefense stockpiling needs.
"Since Sept. 11, BD's goal has been to help governments around the world prepare for mass public immunization for smallpox and other life-threatening bioterror agents," says Zeil Rosenberg, BD's worldwide business leader for immunization. "It is critical to have adequate supplies of the bifurcated needle available in the event worldwide immunization for smallpox becomes necessary."
BD officials are also working on advanced information technology platform that will help facilitate such mass immunizations.
For additional information, visit:
www.bd.com
.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
